Influence of backbone chemistry on immune activation by synthetic oligonucleotides

Biochemical Pharmacology

Volumn 58, Issue 12, 1999, Pages 1981-1988

  Pisetsky, David S ^a   Reich III, Charles F ^a  

^a DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Cytokine production; DNA; Immune stimulation; Mitogenesis; Oligonucleotides; Phosphorothioate

Indexed keywords

CD69 ANTIGEN; DNA BASE; INTERLEUKIN 12; INTERLEUKIN 6; OLIGONUCLEOTIDE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CYTOKINE PRODUCTION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIGENS, CD; INTERLEUKIN-12; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MITOGENS; OLIGONUCLEOTIDES; SPLEEN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032726156     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00294-4     Document Type: Article

References (37)

1. Pisetsky D.S. The immunologic properties of DNA. J Immunol. 156:1996;421-423.
2. Pisetsky D.S. Immune activation by bacterial DNA A new genetic code . Immunity. 5:1996;303-310.
3. Tokunaga T., Yamamoto H., Shimada S., Abe H., Fukuda T., Fujisawa Y., Furutani Y., Yano O., Kataoka T., Sudo T., Makiguchi N., Suganuma T. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst. 72:1984;955-962.
4. Messina J.P., Gilkeson G.S., Pisetsky D.S. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J Immunol. 147:1991;1759-1764.
5. Tokunaga T., Yano O., Kuramoto E., Kimura Y., Yamamoto T., Kataoka T., Yamamoto S. Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiol Immunol. 36:1992;55-66.
6. Yamamoto S., Yamamoto T., Kataoka T., Kuramoto E., Yano O., Tokunaga T. Unique palindromic sequences in synthetic oligonucleotides are required to induce INF and augment INF-mediated natural killer activity. J Immunol. 148:1992;4072-4076.
7. Krieg A.M., Yi A.-K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546-549.
8. Halpern M.D., Kurlander R.J., Pisetsky D.S. Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-α Cell Immunol. 167:1996;72-78.
9. Klinman D.M., Yi A.-K., Beaucage S.L., Conover J., Krieg A.M. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ Proc Natl Acad Sci USA. 93:1996;2879-2883.
10. Weiner G.J., Liu H.-M., Wooldridge J.E., Dahle C.E., Krieg A.M. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc Natl Acad Sci USA. 94:1997;10833-10837.
11. Lipford G.B., Bauer M., Blank C., Reiter R., Wagner H., Heeg K. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen A new class of vaccine adjuvants . Eur J Immunol. 27:1997;2340-2344.
12. Davis H.L., Weeranta R., Waldschmidt T.J., Tygrett L., Schorr J., Krieg A.M. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol. 160:1998;870-876.
13. Sun S., Kishimoto H., Sprent J. DNA as an adjuvant Capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen . J Exp Med. 187:1998;1145-1150.
14. Sato Y., Roman M., Tighe H., Lee D., Corr M., Nguyen M.-D., Silverman G.J., Lotz M., Carson D.A., Raz E. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science. 273:1996;352-354.
15. Klinman D.M., Yamshchikov G., Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol. 158:1997;3635-3639.
16. Frey P.A., Sammons R.D. Bond order and charge localization in nucleoside phosphorothioates. Science. 228:1985;541-545.
17. Stein C.A., Cheng Y.-C. Antisense oligonucleotides as therapeutic agents - Is the bullet really magical? Science. 261:1993;1004-1012.
18. Stein C.A., Subasinghe C., Shinozuka K., Cohen J.S. Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res. 16:1998;3209-3221.
19. Pisetsky D.S., Reich C. Stimulation of in vitro proliferation of murine lymphocytes by synthetic oligodeoxynucleotides. Mol Biol Rep. 18:1993;217-221.
20. Branda R.F., Moore A.L., Lafayette A.R., Mathews L., Hong R., Zon G., Brown T., McCormack J.J. Amplification of antibody production by phosphorothioate oligodeoxynucleotides. J Lab Clin Med. 128:1996;329-338.
21. Liang H., Nishioka Y., Reich C.F., Pisetsky D.S., Lipsky P.E. Activation of human B cells by phosphorothioate oligodeoxynucleotides. J Clin Invest. 98:1996;1119-1129.
22. Monteith D.K., Henry S.P., Howard R.B., Flournoy S., Levin A.A., Bennett C.F., Crooke S.T. Immune stimulation - A class effect of phosphorothioate oligodeoxynucleotides in rodents. Anticancer Drug Des. 12:1997;421-432.
23. Kuramoto E., Yano O., Kimura Y., Baba M., Makino T., Yamamoto S., Yamamoto T., Kataoka T., Tokunaga T. Oligonucleotide sequences required for natural killer cell activation. Jpn J Cancer Res. 83:1992;1128-1131.
24. Pisetsky D.S., Reich C. The influence of base sequence on the immunological properties of defined oligonucleotides. Immunopharmacology. 40:1998;199-208.
25. 3H]thymidine incorporation by "control" oligonucleotides. Antisense Res Dev. 2:1992;325-330.
26. 3H-thymidine incorporation are related to position of thymidine residues in oligodeoxynucleotides. Exp Hematol. 22:1994;384-387.
27. Sun S., Beard C., Jaenisch R., Jones P., Sprent J. Mitogenicity of DNA from different organisms for murine B cells. J Immunol. 159:1997;3119-3125.
28. Zhao Q., Temsamani J., Iadarola P.L., Jiang Z., Agrawal S. Effect of different chemically modified oligodeoxynucleotides on immune stimulation. Biochem Pharmacol. 51:1996;173-182.
29. Hartmann G., Krug A., Waller-Fontaine K., Endres S. Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor Dependence on phosphorothioate modification and reversal by heparin . Mol Med. 2:1996;429-438.
30. Kimura Y., Sonehara K., Kuramoto E., Makino T., Yamamoto S., Yamamoto T., Kataoka T., Tokunaga T. Binding of oligoguanylate to scavenger receptors is required for oligonucleotides to augment NK cell activity and induce IFN. J Biochem (Tokyo). 116:1994;991-994.
31. Krieger M., Herz J. Structures and functions of multiligand lipoprotein receptors Macrophage scavenger receptors and LDL receptor-related protein (LRP) . Annu Rev Biochem. 63:1994;601-637.
32. Krieger M., Acton S., Ashkenas J., Pearson A., Penman M., Resnick D. Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. J Biol Chem. 268:1993;4569-4572.
33. Pearson A.M., Rich A., Krieger M. Polynucleotide binding to macrophage scavenger receptors depends on the formation of base-quartet-stabilized four-stranded helices. J Biol Chem. 268:1993;3546-3554.
34. Lipford G.B., Sparwasser T., Bauer M., Zimmermann S., Koch E.-S., Heeg K., Wagner H. Immunostimulatory DNA Sequence-dependent production of potentially harmful or useful cytokines . Eur J Immunol. 27:1997;3420-3426.
35. Chace J.H., Hooker N.A., Mildenstein K.L., Krieg A.M., Cowdery J.S. Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL-12. Clin Immunol Immunopathol. 84:1997;185-193.
36. Zhao Q., Temsamani J., Zhou R.-Z., Agrawal S. Pattern and kinetics of cytokine production following administration of phosphorothioate oligonucleotides in mice. Antisense Nucleic Acid Drug Dev. 7:1997;495-502.
37. Halpern M.D., Pisetsky D.S. In vitro inhibition of murine IFN-γ production by phosphorothioate deoxyguanosine oligomers. Immunopharmacology. 29:1995;47-52.